Tavanta is focused on the research and development of specialty drugs that deliver meaningful benefits to patients with serious or debilitating disease.
The laboratory operations for the company are located in Budapest, Hungary which provides access to some of the most prestigious regional science hubs and academic centers in the region.
In addition, a Peptide Conjugate Development Platform has been developed to address the challenges associated with conventional peptide development. The platform supports the screening, identification, synthesis and characterization of new peptides and peptide conjugates.
1 Ku S. Wyeth First in Human Formulation Strategy. In AAPS Conference, Oral Presentation 2008.